|
1
|
Ferronato AE, Gilio AE and Vieira SE:
Respiratory viral infections in infants with clinically suspected
pertussis. J Pediatr (Rio J). 89:549–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burr JS, Jenkins TL, Harrison R, Meert K,
Anand KJ, Berger JT, Zimmerman J, Carcillo J, Dean JM, Newth CJ, et
al Eunice Kennedy Shriver National Institute of Child Health and
Human Development (NICHD) Collaborative Pediatric Critical Care
Research Network (CPCCRN), : The Collaborative Pediatric Critical
Care Research Network Critical Pertussis Study: collaborative
research in pediatric critical care medicine. Pediatr Crit Care
Med. 12:387–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Craig-Mylius KA and Weiss AA:
Antibacterial agents and release of periplasmic pertussis toxin
from Bordetella pertussis. Antimicrob Agents Chemother.
44:1383–1386. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hozbor D, Mooi F, Flores D, Weltman G,
Bottero D, Fossati S, Lara C, Gaillard ME, Pianciola L, Zurita E,
et al: Pertussis epidemiology in Argentina: trends over 2004–2007.
J Infect. 59:225–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nelson KE, Gavitt F, Batt MD, Kallick CA,
Reddi KT and Levin S: The role of adenoviruses in the pertussis
syndrome. J Pediatr. 86:335–341. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guiso N, Wirsing von König CH, Forsyth K,
Tan T and Plotkin SA: The Global Pertussis Initiative: report from
a round table meeting to discuss the epidemiology and detection of
pertussis, Paris, France, 11–12 January 2010. Vaccine.
29:1115–1121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cherry JD: Epidemic pertussis in 2012 -
the resurgence of a vaccine-preventable disease. N Engl J Med.
367:785–787. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salimi A, Eybagi S, Seydi E, Naserzadeh P,
Kazerouni NP and Pourahmad J: Toxicity of macrolide antibiotics on
isolated heart mitochondria: a justification for their cardiotoxic
adverse effect. Xenobiotica. 46:82–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shearer MJ: Vitamin K. Lancet.
345:229–234. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shearer MJ: Role of vitamin K and Gla
proteins in the pathophysiology of osteoporosis and vascular
calcification. Curr Opin Clin Nutr Metab Care. 3:433–438. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Caterina R, Husted S, Wallentin L,
Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen
J, Kristensen SD, et al: Vitamin K antagonists in heart disease:
Current status and perspectives (Section III). Position paper of
the ESC Working Group on Thrombosis-Task force on anticoagulants in
heart disease. Thromb Haemost. 110:1087–1107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y: New materia medica project:
synthetic biology based bioactive metabolites research in medicinal
plant. Sheng Wu Gong Cheng Xue Bao. 33:478–485. 2017.(In Chinese).
PubMed/NCBI
|
|
13
|
Koklu E, Taskale T, Koklu S and Ariguloglu
EA: Anaphylactic shock due to vitamin K in a newborn and review of
literature. J Matern Fetal Neonatal Med. 27:1180–1181. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nowak-Göttl U, Dietrich K, Schaffranek D,
Eldin NS, Yasui Y, Geisen C and Mitchell LG: In pediatric patients,
age has more impact on dosing of vitamin K antagonists than VKORC1
or CYP2C9 genotypes. Blood. 116:6101–6105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Per H, Arslan D, Gümüş H, Coskun A and
Kumandaş S: Intracranial hemorrhages and late hemorrhagic disease
associated cholestatic liver disease. Neurol Sci. 34:51–56. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhomberg PR and Jones RN; MYSTIC Program
(USA) Study Group, : Antimicrobial spectrum of activity for
meropenem and nine broad spectrum antimicrobials: report from the
MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis.
47:365–372. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abo El Sooud K: Plasma pharmacokinetics
and urine concentrations of meropenem in ewes. J Vet Pharmacol
Ther. 27:27–30. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Forsyth KD, Wirsing von Konig CH, Tan T,
Caro J and Plotkin S: Prevention of pertussis: recommendations
derived from the second Global Pertussis Initiative roundtable
meeting. Vaccine. 25:2634–2642. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Black RE, Morris SS and Bryce J: Where and
why are 10 million children dying every year? Lancet.
361:2226–2234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tan TQ and Gerbie MV: Pertussis, a disease
whose time has come: What can be done to control the problem?
Obstet Gynecol. 122:370–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Galdi E and Moscato G: Pertussis in the
aetiology of chronic cough in adults. Monaldi Arch Chest Dis.
57:229–230. 2002.PubMed/NCBI
|
|
22
|
Wang J, Yang Y, Li J, Mertsola J,
Arvilommi H, Shen X and He Q: Infantile pertussis rediscovered in
China. Emerg Infect Dis. 8:859–861. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Centers for Disease Control Prevention
(CDC), . Updated recommendations for use of tetanus toxoid, reduced
diphtheria toxoid and acellular pertussis (Tdap) vaccine from the
Advisory Committee on Immunization Practices, 2010. MMWR Morb
Mortal Wkly Rep. 60:13–15. 2011.PubMed/NCBI
|
|
24
|
Horiba K, Nishimura N, Gotoh K, Kawaguchi
M, Takeuchi S, Hattori F, Isaji M, Okai Y, Hosono H, Takemoto K, et
al: Clinical manifestations of children with microbiologically
confirmed pertussis infection and antimicrobial susceptibility of
isolated strains in a regional hospital in Japan, 2008–2012. Jpn J
Infect Dis. 67:345–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benzakour O, Gely A, Lara R and Coronas V:
Gas-6 and protein S: Vitamin K-dependent factors and ligands for
the TAM tyrosine kinase receptors family. Med Sci (Paris).
23:826–833. 2007.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ateskan U, Mas MR, Yasar M, Deveci S,
Babaoglu E, Comert B, Mas NN, Doruk H, Tasci I, Ozkomur ME, et al:
Deferoxamine and meropenem combination therapy in experimental
acute pancreatitis. Pancreas. 27:247–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
